I DON'T MAKE ANY MONEY OFF THIS SITE
If this helps you and you want to make sure it continues, please donate.
Protect Yourself
As an Amazon Associate I earn from qualifying purchases.
Pfizer reaches agreement to resolve Depo-Provera brain tumor MDL
Summary
Pfizer reached an agreement in principle to resolve thousands of lawsuits alleging the company failed to warn consumers about an alleged link between its Depo-Provera contraceptive injection and meningioma brain tumors.... Read More The post Pfizer reaches agreement to resolve Depo-Provera brain tumor MDL appeared first on Top Class Actions.
Read full article →Eligibility
Following the announcement, Judge Rodgers vacated deadlines in the first bellwether case, which had been scheduled for trial in December 2026. The court also postponed a hearing concerning the admissibility of plaintiffs’ causation evidence from June 24 to July 27. The terms of the Pfizer Depo-Provera agreement have not been disclosed. A Pfizer spokesperson said, “The company has reached an agreement in principle with plaintiff leadership in the Depo-Provera MDL that provides an opportunity for MDL plaintiffs to resolve their claims,” as reported by Law360. Pfizer emphasized that the agreement contains no admission of liability or wrongdoing and does not affect cases pending in state courts.